In the latest trading session, Vertex Pharmaceuticals (VRTX) closed at $484.01, marking a +0.11% move from the previous day. This change outpaced the S&P 500's 4.84% loss on the day. At the same time, ...

Analysts have been eager to weigh in on the Healthcare sector with new ratings on Vertex Pharmaceuticals (VRTX – Research Report) and Apellis ...

We recently published a list of 8 Best Gene-Editing Stocks to Buy. In this article, we are going to take a look at where Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) stands against other best ...

RBC Capital raised the firm’s price target on Vertex Pharmaceuticals (VRTX) to $420 from $408 and keeps a Sector Perform rating on the shares.

The 12-month price targets assessed by analysts reveal further insights, featuring an average target of $478.12, a high ...

Vertex is ending work on one of its two clinical-stage islet cell treatments after the diabetes therapy looked unlikely to ...

The equity portion of the Abrdn Healthcare Investors Fund fell (gross of fees) but outperformed its custom benchmark over the ...

Read Our Latest Stock Report on VERX Vertex Stock Down 3.3 % Shares of NASDAQ:VERX opened at $32.88 on Friday. The stock has a market capitalization of $5.13 billion, a P/E ratio of 182.67, a PEG ...

With Matheus Cunha banned and Wolves still in their relegation battle, Hwang will be hoping to return to the form that saw him notch 12 top flight goals last season. Vitor Pereira (Photo by Jack ...

Emma Culligan examines the find, estimating its age to be from the mid to late 1700s. Marty Lagina reacts with intrigue, stating, “That could be pre-searcher. ” This reinforces the idea that ...